North America Keytruda Market Size & Outlook, 2026-2033
Related Markets
North America keytruda market highlights
- The North America keytruda market generated a revenue of USD 11,950.0 million in 2025.
- The market is expected to grow at a CAGR of -3.7% from 2026 to 2033.
- In terms of segment, lung cancer was the largest revenue generating application in 2025.
- Breast Cancer is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 11,950.0 million |
| Market revenue in 2033 | USD 9,605.0 million |
| Growth rate | -3.7% (CAGR from 2026 to 2033) |
| Largest segment | Lung cancer |
| Fastest growing segment | Breast Cancer |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Lung Cancer, Breast Cancer, Melanoma, Hodgkin Lymphoma, Head and Neck Cancer, Gastric Cancer, Urothelial Cancer |
| Key market players worldwide | Merck & Co Inc, Bristol-Myers Squibb Co, Roche Holding AG ADR, Regeneron Pharmaceuticals Inc, Pfizer Inc, Amgen Inc, Samsung Bioepis, Bio-Thera Solutions |
Other key industry trends
- In terms of revenue, North America region accounted for 38.1% of the global keytruda market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 5,879.5 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Keytruda Market Scope
Keytruda Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Bio-Thera Solutions | View profile | 251-500 | Guangzhou, Guangdong, China, Asia | https://bio-thera.com/EN/ |
| Samsung Bioepis | View profile | 501-1000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbioepis.com |
| Regeneron Pharmaceuticals Inc | View profile | 13450 | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 | https://www.regeneron.com |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
North America keytruda market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to keytruda market will help companies and investors design strategic landscapes.
Lung cancer was the largest segment with a revenue share of 27.56% in 2025. Horizon Databook has segmented the North America keytruda market based on lung cancer, breast cancer, melanoma, hodgkin lymphoma, head and neck cancer, gastric cancer, urothelial cancer covering the revenue growth of each sub-segment from 2021 to 2033.
North America leads the Keytruda market with a share of 38.03% due to high cancer prevalence, widespread adoption of immunotherapy, and strong R&D investments.
The Hospital Pharmacy Specialty Pharmacy region benefits from early regulatory approvals and extensive clinical research, particularly in lung cancer and melanoma.
Ongoing trials exploring Keytruda’s use in earlier treatment stages and combination therapies further support market expansion. However, pricing pressures, regulatory scrutiny, and impending biosimilar competition pose challenges to sustained growth.
Reasons to subscribe to North America keytruda market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America keytruda market databook
-
Our clientele includes a mix of keytruda market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America keytruda market , including forecasts for subscribers. This continent databook contains high-level insights into North America keytruda market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America keytruda market size, by country, 2021-2033 (US$M)
North America Keytruda Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
